Drug Information

General Information
Drug ID
DR01411
Drug Name
ABT-737
Synonyms
ABT-737; 852808-04-9; ABT 737; ABT737; UNII-Z5NFR173NV; Z5NFR173NV; 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide; CHEMBL376408; C42H45ClN6O5S2; 4-{4-[(4'-Chlorobiphenyl-2-Yl)methyl]piperazin-1-Yl}-N-{[4-({(1r)-3-(Dimethylamino)-1-[(Phenylthio)methyl]propyl}amino)-3-Nitrophenyl]sulfonyl}benzamide
Drug Type
Small molecular drug
Indication Discovery agent [ICD11: N.A.] Terminated [1]
Structure
3D MOL 2D MOL
Formula
C42H45ClN6O5S2
Canonical SMILES
CN(C)CCC(CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]
InChI
InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1
InChIKey
HPLNQCPCUACXLM-PGUFJCEWSA-N
CAS Number
CAS 852808-04-9
Pharmaceutical Properties Molecular Weight 813.4 Topological Polar Surface Area 165
Heavy Atom Count 56 Rotatable Bond Count 15
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 10
XLogP
9
PubChem CID
11228183
PubChem SID
16311417 , 23409660 , 24771379 , 42307785 , 49700562 , 56311704 , 56314454 , 80047167 , 87557472 , 92729821 , 99003700 , 99431768 , 103505845 , 118043388 , 124756925 , 125163732 , 126582692 , 126723510 , 134344320 , 135262602 , 135727387 , 135727816 , 136367451 , 136920254 , 137220587 , 137507903 , 143499176 , 152236756 , 152258854 , 152344158 , 160647704 , 162011590 , 162037377 , 162202715 , 163391231 , 163685667 , 163842211 , 164045164 , 164194130 , 164834713 , 172087028 , 174007025 , 174316178 , 177748628 , 184814009 , 198934891 , 223683207 , 226522540 , 241155185 , 242585323
TTD Drug ID
D0L8WH
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009496)
2 The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochem Biophys Res Commun. 2011 May 6;408(2):344-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.